http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2015148638-A

Outgoing Links

Predicate Object
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-106
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-178
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68
filingDate 2014-04-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2017-05-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RU-2015148638-A
titleOfInvention TUMOR CELL RESPONSE MARKERS FOR ANTI-CANCER THERAPY
priorityDate 2013-04-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID441203
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60838
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419535155
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419492617
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419535834
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID148124

Total number of triples: 21.